Determination that GEREF (Sermorelin acetate) injection, 0.5 milligrams base/vial and 1.0 milligrams base/vial, and GEREF (Sermorelin acetate) injection, 0.05 milligrams base/amp, were not withdrawn from sale for reasons of safety or effectiveness
The use of sodium-glucose co-transporter-2 inhibitors or glucagon-like peptide-1 receptor agonists versus sulfonylureas and the risk of lower limb amputations: A nation-wide cohort study
Comprehensive studies involving diverse populations are needed to develope and validate integrated care models that can effectively manage both of these comorbid conditions
Novo Nordisk offers savings programs to help reduce the cost for eligible patients, which can significantly lower the price for some people
Our skin naturally shows signs of ageing, such as pigmentation, wrinkles, and sagging